TP53 and cancer: We extended our screen to a comprehensive library of 9,225 variants spanning the p53 DBD from exon 5 to 8 (amino acids 126 to 307), encompassing approximately 94.5% of all cancer-associated missense mutations (Fig. 4a and Supplementary Table 2).